GO:0006580 ethanolamine metabolic process: Phospholipid Synthesis Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006580 ethanolamine metabolic process describes the chemical reactions and pathways involving ethanolamine (2-aminoethanol), a water-soluble base of the phospholipid phosphatidylethanolamine.
• Ethanolamine enters the Kennedy pathway for phosphatidylethanolamine synthesis, and recent structural studies reveal how FLVCR1 and related transporters mediate lipid head group entry.
• Ethanolamine utilization occurs in diverse organisms, from bacteria that use it as a carbon and nitrogen source to mammalian cells that require it for membrane biogenesis.
• Ethanolamine phospholipid synthesis via selenoprotein I is required for effective metabolic reprogramming during T cell activation, linking this pathway to immune function.
• Dysregulation of ethanolamine metabolism has been associated with kidney function, cancer, and platelet biology, making it a target for disease research.
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable causal interrogation of genes in the ethanolamine metabolic process for drug discovery and diagnostics.
Description
Ethanolamine metabolic process (GO:0006580) encompasses the chemical reactions and pathways involving ethanolamine (2-aminoethanol), an important water-soluble base of the phospholipid phosphatidylethanolamine. This process is fundamental to membrane biogenesis, lipid signaling, and cellular metabolism across all domains of life. In humans, ethanolamine must be transported into cells and then activated to enter the Kennedy pathway for phosphatidylethanolamine synthesis, a critical step for membrane integrity and cell proliferation. Recent structural and molecular studies have begun to elucidate the transport mechanisms and enzymatic steps that define this pathway. Beyond its role in phospholipid synthesis, ethanolamine metabolism intersects with immune cell activation, bacterial pathogenesis, and metabolic reprogramming. For example, upregulated ethanolamine phospholipid synthesis via selenoprotein I is required for effective metabolic reprogramming during T cell activation. In bacteria, ethanolamine utilization provides a competitive advantage in the gut, and its regulation is tightly controlled. These findings underscore the broad biological significance of ethanolamine metabolic process and its potential as a therapeutic target. For researchers, understanding GO:0006580 is essential for dissecting lipid metabolism, membrane dynamics, and disease mechanisms. This article provides a comprehensive overview of the pathway, key genes, regulatory mechanisms, disease associations, and cutting-edge research methods, including CRISPR-based models, to accelerate discovery in this field.
ethanolamine metabolic process At A Glance
| GO ID | GO:0006580 |
|---|---|
| GO term | ethanolamine metabolic process |
| Ontology | biological_process |
| Synonym | ethanolamine metabolism |
| Definition | The chemical reactions and pathways involving ethanolamine (2-aminoethanol), an important water-soluble base of phospholipid (phosphatidylethanolamine). |
| Major function | Synthesis of phosphatidylethanolamine, membrane biogenesis, and ethanolamine utilization as a nutrient source. |
| Key enzymes | Ethanolamine kinase (ETNK1/2), CTP:phosphoethanolamine cytidylyltransferase (PCYT2), and phosphatidylethanolamine synthesis enzymes. |
| Transporters | FLVCR1 and related proteins mediate ethanolamine transport. |
| Related pathways | Kennedy pathway, phospholipid biosynthesis, and one-carbon metabolism. |
What Is GO:0006580?
The ethanolamine metabolic process (GO:0006580) is defined as the chemical reactions and pathways involving ethanolamine (2-aminoethanol), an important water-soluble base of phospholipid (phosphatidylethanolamine). This includes the transport, phosphorylation, and incorporation of ethanolamine into phospholipids, as well as its utilization as a carbon or nitrogen source in certain organisms.
Why Is ethanolamine metabolic process Important in Cell Biology?
Ethanolamine metabolic process is critical for maintaining cellular membrane integrity, providing precursors for phosphatidylethanolamine, and supporting rapid cell proliferation. Its dysregulation has been linked to immune disorders, cancer, and kidney dysfunction, making it a focal point for understanding metabolic reprogramming and developing targeted therapies.
• Provides the major phospholipid phosphatidylethanolamine for membrane biogenesis and cell growth.
• Required for effective metabolic reprogramming during T cell activation, linking to immune responses.
• Bacterial ethanolamine utilization contributes to gut colonization and pathogenesis.
• Alterations in ethanolamine-containing lysophospholipids affect platelet aggregation and leukotriene production.
• Genome-wide association studies link urinary ethanolamine metabolites to kidney function.
• Selenoprotein I-dependent ethanolamine phospholipid synthesis supports cancer cell proliferation.
• Ethanolamine transport mechanisms are emerging as drug targets for metabolic diseases.
• The pathway is conserved from bacteria to humans, enabling comparative studies.
• Ethanolamine metabolism intersects with choline metabolism, impacting lipid homeostasis.
• CRISPR screening can identify novel regulators of ethanolamine metabolic process for therapeutic development.
What Happens During ethanolamine metabolic process?
Ethanolamine Transport and Uptake
In simple terms: Ethanolamine is brought into the cell from outside.
Ethanolamine must be transported across the plasma membrane to enter metabolic pathways. Recent structural studies have elucidated the molecular mechanism of choline and ethanolamine transport in humans, identifying key transporters such as FLVCR1 that mediate lipid head group entry to the Kennedy pathway. These transporters are essential for supplying ethanolamine for phosphatidylethanolamine synthesis.
Phosphorylation by Ethanolamine Kinase
In simple terms: Ethanolamine gets a phosphate group added to it.
Once inside the cell, ethanolamine is phosphorylated by ethanolamine kinase (ETNK1/2) to form phosphoethanolamine. This is the first committed step in the Kennedy pathway for phosphatidylethanolamine synthesis. The reaction requires ATP and is regulated by feedback mechanisms.
Activation to CDP-Ethanolamine
In simple terms: Phosphoethanolamine is activated to a high-energy intermediate.
Phosphoethanolamine is converted to CDP-ethanolamine by CTP:phosphoethanolamine cytidylyltransferase (PCYT2). This step is rate-limiting and requires CTP. CDP-ethanolamine then serves as the donor for the final step of phosphatidylethanolamine synthesis.
Phosphatidylethanolamine Synthesis
In simple terms: CDP-ethanolamine is attached to a lipid to make phosphatidylethanolamine.
CDP-ethanolamine reacts with diacylglycerol to form phosphatidylethanolamine, catalyzed by CDP-ethanolamine:diacylglycerol ethanolaminephosphotransferase (CEPT1). This completes the Kennedy pathway. Phosphatidylethanolamine is a major membrane phospholipid and a precursor for phosphatidylcholine and other lipids.
Ethanolamine Utilization in Bacteria
In simple terms: Bacteria can break down ethanolamine to use as food.
In bacteria such as Salmonella and Streptomyces, ethanolamine can be utilized as a carbon and nitrogen source. The ethanolamine utilization (eut) operon encodes enzymes that convert ethanolamine to acetaldehyde and ammonia. This pathway is regulated by the EutR transcription factor and is important for gut colonization.
Key Genes Involved in GO:0006580 ethanolamine metabolic process
The following genes and proteins are key players in ethanolamine metabolic process, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ETNK1 | Ethanolamine kinase; phosphorylates ethanolamine | Mutations linked to cancer and metabolic disorders |
| ETNK2 | Ethanolamine kinase isoform | Tissue-specific roles in lipid metabolism |
| PCYT2 | CTP:phosphoethanolamine cytidylyltransferase; rate-limiting enzyme | Defects cause complex hereditary spastic paraplegia |
| CEPT1 | CDP-ethanolamine:diacylglycerol ethanolaminephosphotransferase | Final step of phosphatidylethanolamine synthesis |
| FLVCR1 | Ethanolamine transporter; mediates lipid head group entry | Structural basis for Kennedy pathway entry |
| SELENOI | Selenoprotein I; ethanolamine phosphotransferase | Required for T cell activation and metabolic reprogramming |
| CHKA | Choline kinase; overlaps with ethanolamine metabolism | Choline and ethanolamine transport mechanisms |
| CHKB | Choline kinase beta; related to ethanolamine kinase | Muscular dystrophy and lipid metabolism |
| PEMT | Phosphatidylethanolamine N-methyltransferase | Converts phosphatidylethanolamine to phosphatidylcholine |
| PLA2G | Phospholipase A2; releases ethanolamine-containing lysophospholipids | Platelet aggregation and leukotriene production |
| EUTR | Bacterial ethanolamine utilization regulator | Regulates eut operon in bacteria |
| EUTB | Ethanolamine ammonia-lyase subunit | Bacterial ethanolamine degradation |
| EUTC | Ethanolamine ammonia-lyase subunit | Bacterial ethanolamine degradation |
| EUTG | Ethanolamine utilization protein | Bacterial ethanolamine metabolism |
| EUTH | Ethanolamine utilization protein | Bacterial ethanolamine metabolism |
| EUTD | Phosphotransacetylase in eut pathway | Bacterial ethanolamine utilization |
| EUTE | Ethanolamine utilization protein | Bacterial ethanolamine metabolism |
| EUTJ | Ethanolamine utilization protein | Bacterial ethanolamine metabolism |
How Is ethanolamine metabolic process Regulated?
Ethanolamine metabolic process is regulated at multiple levels. In bacteria, the eut operon is controlled by the EutR transcription factor in response to ethanolamine availability. In mammalian cells, the Kennedy pathway is regulated by feedback inhibition and substrate availability, with PCYT2 as a rate-limiting enzyme. Additionally, selenoprotein I-dependent ethanolamine phospholipid synthesis is required for metabolic reprogramming during T cell activation, linking this pathway to immune signaling. Mitochondrial uncoupling can induce epigenome remodeling and promote differentiation in neuroblastoma, potentially affecting ethanolamine metabolism.
ethanolamine metabolic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SELENOI | Cancer, T cell activation | Knockout in Jurkat cells; overexpression in cancer lines |
| PCYT2 | Hereditary spastic paraplegia | Point mutation knock-in in iPSCs; KO in neuronal cells |
| FLVCR1 | Metabolic disorders, kidney function | Knockout in HEK293; transport assays |
| ETNK1 | Cancer, metabolic disorders | Point mutation knock-in; KO in cancer cell lines |
| PLA2G | Cardiovascular disease, inflammation | Overexpression in platelets; KO in megakaryocytes |
Cancer and Metabolic Reprogramming
Upregulated ethanolamine phospholipid synthesis via selenoprotein I is required for effective metabolic reprogramming during T cell activation, and this pathway is also hijacked in cancer cells to support rapid proliferation. Targeting ethanolamine metabolism may offer therapeutic opportunities in cancers dependent on phosphatidylethanolamine synthesis.
Kidney Function and Metabolite Associations
Genome-wide characterization of urinary metabolites has revealed molecular impact of kidney function, with ethanolamine metabolites among those associated with kidney traits. This suggests that ethanolamine metabolic process may be relevant to kidney disease pathophysiology.
Platelet Biology and Inflammation
Ethanolamine-containing lysophospholipid generation in activated human platelets affects aggregation and leukotriene production, linking ethanolamine metabolism to cardiovascular and inflammatory diseases.
Neuroblastoma Differentiation
Mitochondrial uncoupling induces epigenome remodeling and promotes differentiation in neuroblastoma, a process that may involve changes in ethanolamine metabolism. Further research is needed to establish direct links.
From ethanolamine metabolic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of ETNK1 affect phosphatidylethanolamine synthesis? | ETNK1 knockout cell line (e.g., HeLa) |
| Does a specific PCYT2 mutation cause enzyme dysfunction? | PCYT2 point mutation knock-in (e.g., R212W) |
| Can we tag FLVCR1 to study its localization? | FLVCR1 tagged knock-in (e.g., GFP) in HEK293 |
| Does overexpression of SELENOI enhance T cell activation? | SELENOI overexpression in primary T cells |
| What genes regulate ethanolamine utilization in bacteria? | CRISPR interference (CRISPRi) library in E. coli |
| Can we identify novel regulators of ethanolamine metabolism? | Genome-wide CRISPR knockout screen in cancer cells |
How to Study the ethanolamine metabolic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout screen | Gene essentiality and pathway dependencies | Identify regulators of ethanolamine metabolism |
| Lipidomics (LC-MS) | Phosphatidylethanolamine and intermediates | Quantify pathway flux |
| RNA-seq | Transcriptional changes | Assess gene expression after perturbation |
| Proteomics | Protein abundance and modifications | Detect post-translational regulation |
| Transport assays | Ethanolamine uptake rates | Characterize transporter function |
| Cryo-EM | Protein structure | Understand transport mechanism |
| Metabolomics | Small molecule levels | Measure ethanolamine and derivatives |
CRISPR Screening for Pathway Regulators
Genome-wide CRISPR knockout or activation screens can identify genes that modulate ethanolamine metabolic process. For example, screening in cancer cells under ethanolamine-limiting conditions can reveal synthetic lethal interactions.
Metabolomics and Lipidomics
Mass spectrometry-based metabolomics and lipidomics quantify ethanolamine, phosphoethanolamine, CDP-ethanolamine, and phosphatidylethanolamine levels, providing direct readouts of pathway activity.
Structural Biology and Transport Assays
Cryo-EM and X-ray crystallography have elucidated the structure of ethanolamine transporters like FLVCR1, while radiolabeled uptake assays measure transport kinetics.
RNA-seq and Proteomics
Transcriptomic and proteomic profiling after genetic perturbation reveals downstream effects on lipid metabolism genes and pathways, helping to map regulatory networks.
How CRISPR Can Be Used to Study GO:0006580 ethanolamine metabolic process
Knockout
CRISPR knockout of genes such as ETNK1, PCYT2, or FLVCR1 can abolish ethanolamine metabolic process, leading to reduced phosphatidylethanolamine levels and growth defects. These models are valuable for studying pathway essentiality and identifying compensatory mechanisms.
Point Mutation
Introducing disease-associated point mutations (e.g., in PCYT2) via CRISPR knock-in allows researchers to study enzyme dysfunction and its impact on lipid metabolism, mimicking human hereditary spastic paraplegia.
Knock-in
Tagged knock-in of FLVCR1 or SELENOI with fluorescent or affinity tags enables real-time imaging and proteomic analysis of these proteins in their native context, revealing subcellular localization and interaction partners.
Overexpression
CRISPR activation (CRISPRa) or cDNA overexpression of SELENOI or ETNK1 can enhance ethanolamine phospholipid synthesis, useful for studying metabolic reprogramming in T cells and cancer cells.
How EDITGENE Supports ethanolamine metabolic process Research
Researchers studying ethanolamine metabolic process-related genes often need to determine whether a candidate gene is causally involved in pathway regulation, disease progression, or therapeutic response. EDITGENE provides comprehensive CRISPR gene editing services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for ethanolamine metabolic process research.
Frequently Asked Questions About ethanolamine metabolic process
What is ethanolamine metabolic process?
Ethanolamine metabolic process (GO:0006580) encompasses the chemical reactions and pathways involving ethanolamine, a water-soluble base of phosphatidylethanolamine, including its transport, phosphorylation, and incorporation into phospholipids.
What genes are involved in ethanolamine metabolic process?
Key genes include ETNK1, ETNK2, PCYT2, CEPT1, FLVCR1, and SELENOI, which mediate transport, phosphorylation, and phosphatidylethanolamine synthesis.
How is ethanolamine transported into cells?
Ethanolamine is transported by specific transporters such as FLVCR1, which mediates lipid head group entry to the Kennedy pathway.
What is the Kennedy pathway?
The Kennedy pathway is the main route for phosphatidylethanolamine synthesis, where ethanolamine is phosphorylated, activated to CDP-ethanolamine, and combined with diacylglycerol.
What diseases are associated with ethanolamine metabolism?
Dysregulation has been linked to cancer, kidney dysfunction, hereditary spastic paraplegia, and platelet disorders.
How can CRISPR be used to study ethanolamine metabolism?
CRISPR knockout, point mutation knock-in, and overexpression models allow researchers to dissect gene function and pathway regulation in ethanolamine metabolism.
What is the role of SELENOI in ethanolamine metabolism?
Selenoprotein I (SELENOI) is an ethanolamine phosphotransferase required for effective metabolic reprogramming during T cell activation.
Can ethanolamine be used as a carbon source by bacteria?
Yes, bacteria such as Salmonella and Streptomyces utilize ethanolamine as a carbon and nitrogen source via the eut operon.
What are the clinical implications of ethanolamine metabolism?
Alterations in ethanolamine metabolism affect membrane integrity, immune function, and kidney physiology, offering targets for therapeutic intervention.
How does ethanolamine metabolism relate to choline metabolism?
Ethanolamine and choline share transport mechanisms and enzymatic steps in phospholipid synthesis, with overlapping regulatory features.
Conclusion
Ethanolamine metabolic process (GO:0006580) is a fundamental biological pathway that supports membrane biogenesis, immune cell function, and bacterial pathogenesis. Recent advances in structural biology and CRISPR screening have illuminated key transporters and enzymes, opening new avenues for therapeutic targeting in cancer, kidney disease, and metabolic disorders. By leveraging EDITGENE's comprehensive CRISPR services, researchers can generate precise knockout, point mutation, knock-in, and overexpression models to dissect the causal roles of ethanolamine metabolism genes, accelerating discovery and translational applications.
References
- 1. Ri K et al.. 2024. Molecular mechanism of choline and ethanolamine transport in humans.. Nature 630(8016):501-508 PMID: 38778100
- 2. Son Y et al.. 2024. Structural basis of lipid head group entry to the Kennedy pathway by FLVCR1.. Nature 629(8012):710-716 PMID: 38693265
- 3. Jiang H et al.. 2023. Mitochondrial Uncoupling Induces Epigenome Remodeling and Promotes Differentiation in Neuroblastoma.. Cancer Res 83(2):181-194 PMID: 36318118
- 4. Kaval KG et al.. 2018. Ethanolamine Utilization in Bacteria.. mBio 9(1) PMID: 29463652
- 5. Turini ME et al.. 1994. Effects of a fish-oil and vegetable-oil formula on aggregation and ethanolamine-containing lysophospholipid generation in activated human platelets and on leukotriene production in stimulated neutrophils.. Am J Clin Nutr 60(5):717-24 PMID: 7942578
- 6. Ma C et al.. 2021. Upregulated ethanolamine phospholipid synthesis via selenoprotein I is required for effective metabolic reprogramming during T cell activation.. Mol Metab 47:101170 PMID: 33484950
- 7. Krysenko S et al.. 2019. Initial Metabolic Step of a Novel Ethanolamine Utilization Pathway and Its Regulation in Streptomyces coelicolor M145.. mBio 10(3) PMID: 31113893
- 8. Valo E et al.. 2025. Genome-wide characterization of 54 urinary metabolites reveals molecular impact of kidney function.. Nat Commun 16(1):325 PMID: 39746953
